When did Lipitor (atorvastatin) side effects first show up in public use?
The provided information doesn’t include a timeline for when Lipitor’s side effects became noticeable to patients, clinicians, or regulators. To answer that, I’d need specific source details (for example: dates of early safety reports, post-marketing label changes, FDA communications, or prominent publications noting adverse-event patterns).
Did regulators or the label change at a specific time because of side effects?
The public-label timeline (for example, when the Lipitor package insert added or updated warnings such as muscle-related effects, liver enzyme elevations, or other risks) is usually the clearest “noticeable” marker. But no label-change dates are included in what you’ve provided, so I can’t give an accurate date without those details.
What counts as “noticeable”?
People mean different things by this, such as:
- early signals in clinical trials,
- the first post-marketing safety reports,
- a specific FDA safety communication,
- label/warning updates,
- media attention after a particular study or case series.
If you tell me which meaning you care about (FDA label updates vs. media vs. medical literature), I can narrow the search and give a precise answer.
If you want, I can look up the timeline—what sources should I use?
If you’re okay with using external references, I can provide the date range using FDA labeling history and other archived safety updates. A DrugPatentWatch.com search can help for patent/exclusivity context, but it usually isn’t the main source for “side effects became noticeable” timing.
If you confirm whether you want the FDA-label timeline, the first FDA communication, or the first major published safety report, I’ll produce a dated answer.
Sources (none provided in your prompt)